Title: Unit 11: Drugs that affect the CNS
1Unit 11 Drugs that affect the CNS
- Nancy Pares, RN, MSN
- NURS 1950
- Metropolitan Community College
2Obj. 1 Describe the general cause of seizures
and the two major clinical findings associated
with seizures.
- Seizures
- Abnormal or uncontrolled neuronal discharges in
the brain - affect
- Consciousness
- Motor activity
- Sensation
- Symptom of an underlying disorder-not a disease
itself
3Obj 2 Factors that precipitate seizures
- Infectious diseases
- Trauma
- Metabolic disorders
- Vascular diseases
- Pediatric disorders
- Neoplastic diseases
4Different etiologies of seizure activity
- Most common serious neurologic problem affecting
children - May present as an acute situation, or they may
occur on a chronic basis
5- Figure 15.1 EEG recordings showing the
differences between normal, absence seizure, and
generalized tonicclonic seizure tracings
6Drugs as cause of seizures
- High dose of local anesthetics
- Drug abuse
- Withdrawal from alcohol
- Withdrawal from sedative-hypnotics
7Convulsion
- Involuntary violent spasm of large muscles of the
face, neck, arms and legs - Not synonymous with seizure
8Obj. 3 Name and describe major types of
epileptic seizures
- Signs and symptoms
- Related to the area of the brain with abnormal
activity - Types-based on International Classification
- Partial (focal)
- Generalized
- Special epileptic syndromes
9Simple partial (focal) seizures
- Occur in limited portion of brain
- Point of origin abnormal focus or foci
- Clients experience
- Feeling that is vague
- Hallucinations with all senses
- Extreme emotions
- Twitching of arms, legs or face
10Complex partial (focal) seizures
- Altered levels of consciousness
- Involve sensory, motor, autonomic symptoms
- Aura commonly precedes seizure
- No memory of seizure
11Generalized seizures
- Travel throughout the entire brain
- Subcatagories
- Absence
- Atonic
- Tonic-clonic
12Absence seizures
- Common in children
- Subtle symptoms
- Staring
- Transient loss of consciousness
- Eyelid fluttering
- Myclonic jerks
13Atonic seizures
- Usually last only a few seconds
- Characterized by stumbling or falling
14Tonic clonic
- Most common
- Usually preceded by aura
- Tonic phase
- Intense muscle contractions
- Hoarse cry at onset
- Loss of bowel/bladder control
- Shallow breathing
15Tonic clonic, cont
- Clonic phase
- Alternating contraction and relaxation of muscles
- Postictal state (post seizure)
- Drowsiness, disorientation, deep sleep
16Special epileptic syndromes
- Febrile seizures
- Myoclonic seizures
- Status epilepticus
17Febrile seizures
- Last one two minutes
- Tonic clonic motor activity
- Common in 3-5 year olds
- Occur with rapid rise in body temperature
- Affect 5 of all children
18Myoclonic seizures
- Large jerking body movements
- Quick contraction of major muscles
- Stumbling and falling
- Similar to normal infantile Moro reflex
19Status epilepticus
- Medical emergency
- Continuously repeating seizure
- Common with generalized tonic-clonic
- Continuous muscle contractions
- May compromise airway
- May cause hypoglycemia, hypothermia, acidosis
- May produce lactic acid
20Obj. 4, 5, 6,and 7 (inclusive)
- The choice of drug depends upon
- Type of seizure
- Client history and diagnostic studies
- Pathologic process causing seizures
21Once Medication is Selected
- Patient placed on low initial dose
- Amount gradually increased
- If seizure activity remains, different medication
added in small increments - Newer antiseizure drugs have less adverse side
effects than older drugs - Most cases require only a single drug
22(No Transcript)
23New FDA Warnings
- Study included patients with epilepsy, bipolar
disorder, psychoses, migraines, and neuropathic
pain - Popular antiseizure examples found to almost
double risk of suicidal behavior and ideation
24Antiseizure Pharmacotherapy
- Goal suppress neuronal activity enough to
prevent abnormal or repetitive firing - Drugs act through three mechanisms
- Stimulating an influx of chloride ions
- Delaying an influx of sodium
- Delaying an influx of calcium
25Antiseizure Pharmacotherapy (cont'd)
- Directed at controlling movement of electrolytes
across neuronal membranes or affecting
neurotransmitter balance - Some drugs act by more than one mechanism
26Pharmacotherapy Illustrated Model of the GABA
ReceptorChloride Channel Molecules in
Relationship to Antiseizure Pharmacotherapy
27Barbiturates and GABA Agents
- GABA gamma aminobutyric acid
- Primary neuro transmitter of brain.
- Drugs that potentiate GABA action
- Barbiturates
- Benzodiazepines
- Misc. agents
28Barbiturates
- Prototype phenobarbital (Luminal)
- Mechanism of action
- Changing the action of GABA
- Primary use
- Controlling seizures
- Adverse effects
- Dependence, drowsiness, vitamin deficiencies,
laryngeospasm
29Benzodiazepines
- Prototype diazepam (Valium)
- Mechanism of action
- Similar to barbiturates, but safer
- Primary use
- Short term seizure control
- Adverse effects
- Drowsiness and dizziness
30Miscellaneous GABA Agents
- Prototype valproic acid (Depakene)
- Mechanism of action
- similar to benzos and barbiturates
- Primary use
- Adjunct therapy
- Adverse effects
- Sedation, drowsiness, GI upset, prolonged
bleeding time
31Hydantoins
- Prototype phenytoin (Dilantin)
- Mechanism of action
- Desensitize sodium channel blockers
- Primary use
- Treatment of all types of seizures, except
absence seizures - Adverse effects
- CNS depression, gingival hyperplasia, skin rash,
cardiact dysrhythmias, and hypotension
32Phenytoin-like Drugs
- Prototype drug valproic acid (Depakene)
- Mechanism of action
- Desensitize sodium channels
- Primary use
- Absence seizures
- Adverse effects
- Limited CNS depression, visual disturbances,
ataxia, vertigo, HA, GI, hepatotoxicity,
pancreatitis
33Succinimides
- Prototype ethosuximide (Zarontin)
- Mechanism of action
- Suppress calcium influx
- Primary use
- Absence seizures
- Adverse effects
- Rare, but include drowsiness, dizziness, lethargy
- Rare, but serious lupus, leukopenia, aplastic
anemia, Stevens-Johnson syndrome
34Nurses role in pharmacological management
- Barbiturates
- Monitor for liver and kidney function
- Category D in pregnancy
- Depletion of nutrients
- Alcohol and ginko biloba interactions
- Client teaching
- Use reliable contraception
- Immediately report pregnancy
- Report excessive bleeding,drowsiness, bone pain
- Avoid alcohol and gingko biloba
35Benzodiazepines-schedule IV drug
- Monitor for drug abuse potential
- Pregnancy risk (category D)
- Contraindicated in narrow angle glaucoma
- Liver and kidney function monitored
- Respiratory depression
- In event of overdose
- Give flumazenil (Romazicon)
36Status epilepticus
- Give IV valium and ativan
- Do not mix with other drugs in IV line
- Client teaching
- Avoid ETOH, OTC drugs, herbal preps, nicotine,
driving and hazardous activities - Rebound seizures if d/c abruptly
- Take with food
- These drugs most often used illegally
37Hydantoin and Phenytoin-like drugs
- Monitor serum drug levels, liver and kidney
function - Monitor for bleeding disorders
- Fatal hepatotoxicity can occur
- Contraindicated
- Hx of heart block or seizures due to low BS
- Client teaching
- Routine labs report s/s of toxicity, bleeding,
pregnancy, hypoglycemia
38Succinimides
- Monitor for liver and kidney function
- Pregnancy category C
- Adverse reactions
- Drowsiness, HA, euphoria, n/v, weight loss, abd.
Pain - Life threatening reactions
- Mental depression with suicide intent
- Blood dyscrasias and Stevens-Johnson syndrome
39Succinimides
- Symptoms of overdose
- CNS depression, stupor, ataxia, coma
- Client teaching
- Report mood changes or suicidal thoughts
- Avoid driving and hazardous activities
- Take with food
- Do not stop abruptly
- Report weight loss and anorexia
40General client teachings for epilepsy
- Start with smallest dose of med
- Add additional drugs, if needed
- Monitor serum drug levels
- Withdrawal of meds
- Seizure free for three years
- Done gradually
- Resume meds if seizures return
- Knowledge of rebound seizures
41Nursing diagnosis for epilepsy
- Disturbed sensory perception RT seizure activity
- Risk for injury RT seizure activity
- Deficient knowledge RT disease/drugs
- Noncompliance RT drug regime
- Noncompliance RT serum lab testing
42Goals in epilepsy treatment
- Absence/reduction in number of seizures
- No injury during seizure
- Understanding of disease
- Understanding of drug regimen
- Compliance with lab testing
43- Objective 8 Describe common symptoms of
Parkinsons Disease. - Objective 9 Describe the role of dopamine in
the body. - Objective 10 name the preparations used to
treat Parkinsons.
44- Objective 11 describe the role of the
anticholinergic drugs in the treatment of
Parkinsons - Objective 12 Apply nursing process as it relates
to the care of the client with Parkinsons and
accompanying drug therapy.
45Parkinsons Disease
- Second most common CNS disease
- Progressive loss of dopamine
- Tremor, muscle rigidity
- Abnormal movement and posture
46(No Transcript)
47Symptoms of Parkinsons Disease
- Symptoms known as parkinsonism
- Tremors
- Muscle rigidity
- Bradykinesia
- Postural instability
- Affective flattening
48Health Problems in Parkinsons Patients
- Primarily affects muscle movement
- Patients often experience other health issues
- Anxiety, depression
- Sleep disturbances
- Dementia
- Autonomic nervous system disturbances
49Cause of Symptoms
- Degeneration and destruction of
dopamine-producing neurons - Substantia nigra portion of brain
- Corpus striatum
- Normally controls unconsciousness muscle movement
50Neurotransmitters
- Dopamine and acetylcholine in corpus striatum
- Affect balance, posture
- Affect muscle tone, involuntary movement
- Absence of dopamine
- Allows acetylcholine stimulation
51Drug Therapy for Parkinsonism
- Restores dopamine function
- Blocks acetylcholine
- Extrapyramidal side effects (EPS)
52(No Transcript)
53Antiparkinsonism Agents
- Restore balance of dopamine and acetylcholine in
brain - Dopaminergic drugs
- Dopaminergic adjunct agents
- Anticholinergics (cholinergic blockers)
54Dopaminergics
- Restore balance of dopamine and acetylcholine
- Dopaminergic examples
- Levodopa (Larodopa),
- Levodopa and carbidopa (Sinemet)
55Levodopa (Larodopa)
- Levodopa (Larodopa) is drug of choice
- Increases biosynthesis of dopamine within nerve
terminals - Effectiveness boosted by combining with carbidopa
(Sinemet)
56Dopaminergic Adjunct Agents
- Inhibit enzymes
- Example Tolcapone (Tasmar)
- Activate dopamine receptors (dopamine agonists)
- Example Ropinirole (Requip)
- Cause dopamine release from nerve terminals
- Example Amantadine (Symmetrel)
57Anticholinergic Agents
- Centrally acting
- Block acetylcholine
- Inhibits overactivity in brain
- Used in early stages
- Examples
- Benztropine mesylate (Cogentin)
- Triexyphenidyl hydrochloride (Artane)
58Catechol-O-Methyl Transferase (COMT) Inhibitors
- Reduce requirement for L-dopa
- Increase concentration of existing dopamine
improve motor fluctuations - Examples
- entacapone (Comtan)
- tolcapone (Tasmar)
59Dopaminergic Agents
- Prototype drug levodopa (Larodopa)
- Mechanism of action Increases biosynthesis of
dopamine within nerve terminals - Primary use to restore dopamine function or
stimulate dopamine receptors within the brain
60Dopaminergic Agents (continued)
- Adverse effects dizziness, light-headedness,
sleep dysfunction, fatigue, nausea, vomiting,
constipation, orthostatic hypertension, dystonia,
dyskinesia
61(No Transcript)
62(No Transcript)
63Levadopa Animation
- Click here to view an animation on the topic of
levadopa.
64Anticholinergic Agents
- Prototype drug benztropine mesylate (Cogentin)
- Mechanism of action block acetylcholine inhibit
overactivity in brain - Primary use in early stages of disease
- Adverse effects dry mouth, blurred vision,
photophobia, urinary retention, constipation,
tachycardia, glaucoma
65(No Transcript)
66(No Transcript)
67Role of the Nurse Dopaminergic Drug Therapy
- Contraindicated in narrow-angle glaucoma
- Monitor for hypotension and tachycardia
- Look for symptoms of drug toxicity
68Dopaminergics Client Teaching
- Increase fiber and fluids
- Avoid food and drugs high in pyridoxine
- May take several months for full effect
- Abruptly stopping the drug may cause Parkinsonism
crisis
69Anticholinergics Client Teaching
- Relieve dry mouth with frequent drinks or
sugarless hard candy - Take with food or milk to prevent GI upset
- Avoid alcohol
- Wear dark glasses avoid bright sunlight
- Do not stop taking abruptly
70Nursing Considerations with AChE Inhibitors
- Assess baseline vitals
- Monitor for hypotension
- Monitor for change in mental status or mood
- Monitor for dizziness, insomnia, anorexia
- Clients with narrow-angle glaucoma should not
take revastigmine (Exelon)
71Obj. 13 define sedative and hypnotic
- Sedative
- An agent that calms nervousness, irritability and
excitement - Hypnotic
- An agent that induces sleep
72- Objective 14 describe actions, use and s/e of
barbiturates (covered earlier) - Objective 15 identify the commonly used
barbiturates and benzo (covered earlier)
73Obj. 16 Name the conditions that may cause
muscle spasticity.
- Results from damage to the motor area of the
cerebral cortex - Conditions
- Cerebral palsy
- severe head injury, spinal cord injury or
lesions - stroke
- dystonia
74Obj. 17 Goals of drug therapy for muscle spasms
- Goals of muscle relaxants
- Minimize discomfort
- Increase ROM
- Improve ability to function independently
75Obj. 18 Name the musculoskeletal relaxants
- Centrally acting muscle relaxants
- Prototype cyclobenzaprine (Flexeril)
- Mechanism of action
- Inhibits upper motor neuron activity
- Alters simple spinal reflexes, causes CNS
depression - Primary Use
- Treat localized spasms
- Adverse effects
- CNS depression, hepatic toxicity, physical
dependence, anticholinergic effects
76Obj. 18 cont
- Direct acting antispasmodics
- Prototype dantrolene (Danantrium)
- Mechanism of action
- Interferes with release of calcium ions in
skeletal muscle - Primary use
- Relieve dystonias and leg cramps
- Adverse effects
- Hepatic toxicity, muscle weakness, drowsiness,
diarrhea
77Obj. 19 Nursing process for CNS drugs
- Assessment
- Monitor pain, LOC, vital signs
- Monitor muscle tone, ROM, degree of spasms
- Monitor labs
- Nursing Dx
- Pain
- Impaired physical mobility
- Risk for injury
- Deficient knowledge
78Obj. 19 cont
- Goals
- Decrease pain
- Increase range of motion (ROM)
- Reduce muscle spasms
- No adverse effects of drugs
- Knowledge of drug regimen